Celldex
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Celldex and other ETFs, options, and stocks.About CLDX
Celldex Therapeutics, Inc. engages in the business of development, manufacturing and commercialization of novel therapeutics for human health care. Its drug candidates have the ability to engage the human immune system and directly inhibit tumors to treat specific types of cancer and other diseases.
CEOAnthony S. Marucci
CEOAnthony S. Marucci
Employees186
Employees186
HeadquartersHampton, New Jersey
HeadquartersHampton, New Jersey
Founded1983
Founded1983
Employees186
Employees186
CLDX Key Statistics
Market cap1.75B
Market cap1.75B
Price-Earnings ratio-7.77
Price-Earnings ratio-7.77
Dividend yield—
Dividend yield—
Average volume676.58K
Average volume676.58K
High today$26.37
High today$26.37
Low today$25.15
Low today$25.15
Open price$25.53
Open price$25.53
Volume771.03K
Volume771.03K
52 Week high$30.50
52 Week high$30.50
52 Week low$14.40
52 Week low$14.40
Stock Snapshot
Celldex(CLDX) stock is priced at $26.28, giving the company a market capitalization of 1.75B. It carries a P/E multiple of -7.77.
As of 2026-01-07, Celldex(CLDX) stock has fluctuated between $25.15 and $26.37. The current price stands at $26.28, placing the stock +4.5% above today's low and -0.3% off the high.
The Celldex(CLDX)'s current trading volume is 771.03K, compared to an average daily volume of 676.58K.
During the past year, Celldex(CLDX) stock moved between $14.40 at its lowest and $30.50 at its peak.
During the past year, Celldex(CLDX) stock moved between $14.40 at its lowest and $30.50 at its peak.
Analyst ratings
80%
of 15 ratingsBuy
80%
Hold
13.3%
Sell
6.7%
People also own
Based on the portfolios of people who own CLDX. This list is generated using Robinhood data, and it’s not a recommendation.